New Republic Capital »

Crispr Therapeutics shares owned by New Republic Capital

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by New Republic Capital from 13F filings

Historical chart of New Republic Capital investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by New Republic Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by New Republic Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $314k 5.8k 54.54

More positions owned by New Republic Capital

Apple (AAPL)
Gmo Etf Trust Us Quality Etf (QLTY)
Morgan Stanley Com New (MS)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Ishares Tr Russell 3000 Etf (IWV)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
First Tr Exchange-traded No Amer Energy (EMLP)
Doubleline Etf Trust Mortgage Etf (DMBS)
Ishares Msci Japan Etf (EWJ)
Alphabet Cap Stk Cl A (GOOGL)
Norfolk Southern (NSC)
Ishares Tr Msci Eafe Etf (EFA)
Amazon (AMZN)

View all positions for New Republic Capital

Top funds holding Crispr Therapeutics

ARK Investment Management
BlackRock
Orbis Allan Gray
Capital World Investors
State Street Corporation
GSK
Geode Capital Management
Sr One Capital Management
Two Sigma Investments
FMR
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
EcoR1 Capital
UBS Group
Capital Research and Management Company - Division 3

View all funds holding Crispr Therapeutics